Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06430385
Status:
RECRUITING
Last Update Posted:
2024-05-28
First Post:
2024-05-21
Brief Title:
ATTUNE A Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 MECP2 Duplication Syndrome MDS
Sponsor:
Ionis Pharmaceuticals Inc
Organization:
Ionis Pharmaceuticals Inc
Organization Data
Organization:
Ionis Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
ION440-CS1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ionis Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None